On Tuesday, Cogent Biosciences Inc (NASDAQ: COGT) opened higher 5.67% from the last session, before settling in for the closing price of $10.93. Price fluctuations for COGT have ranged from $3.72 to $12.97 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.02%. Company’s average yearly earnings per share was noted 12.52% at the time writing. With a float of $117.32 million, this company’s outstanding shares have now reached $139.70 million.
Let’s determine the extent of company efficiency that accounts for 205 employees. In terms of profitability, gross margin is -2.07%, operating margin of -6981.9%, and the pretax margin is -6618.73%.
Cogent Biosciences Inc (COGT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cogent Biosciences Inc is 16.02%, while institutional ownership is 84.71%. The most recent insider transaction that took place on Jul 10 ’25, was worth 24,999,993. In this transaction Director of this company bought 2,777,777 shares at a rate of $9.00, taking the stock ownership to the 9,003,418 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Commercial Officer bought 43,750 for $7.60, making the entire transaction worth $332,412. This insider now owns 45,848 shares in total.
Cogent Biosciences Inc (COGT) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.64 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.57) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.62% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Check out the current performance indicators for Cogent Biosciences Inc (COGT). In the past quarter, the stock posted a quick ratio of 4.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.42, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.82 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Looking closely at Cogent Biosciences Inc (NASDAQ: COGT), its last 5-days average volume was 1.37 million, which is a drop from its year-to-date volume of 2.0 million. As of the previous 9 days, the stock’s Stochastic %D was 42.90%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 84.65%, which indicates a significant increase from 53.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.53 in the past 14 days, which was higher than the 0.50 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.39, while its 200-day Moving Average is $8.02. However, in the short run, Cogent Biosciences Inc’s stock first resistance to watch stands at $11.76. Second resistance stands at $11.96. The third major resistance level sits at $12.35. If the price goes on to break the first support level at $11.16, it is likely to go to the next support level at $10.77. Now, if the price goes above the second support level, the third support stands at $10.57.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
There are currently 113,856K shares outstanding in the company with a market cap of 1.61 billion. Presently, the company’s annual sales total 0 K according to its annual income of -255,860 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -73,530 K.
